Month: January 2023

Targa Resources Corp. to Acquire Blackstone Energy Partners’ 25% Interest in Grand Prix NGL Pipeline for $1.05 Billion

Written by Customer Service on January 3, 2023. Posted in Mergers And Acquisitions.

HOUSTON, Jan. 03, 2023 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today a definitive agreement to acquire Blackstone Energy Partners’ (“Blackstone”) 25 percent interest in Targa’s Grand Prix NGL Pipeline (“Grand Prix”) for $1.05 billion in cash plus customary working capital adjustments. Targa will own 100 percent of Grand Prix upon closing. Grand Prix has capacity to transport up to one million barrels per day of natural gas liquids (“NGL”) to the NGL market hub at Mont Belvieu, Texas. Grand Prix connects Targa’s gathering and processing positions throughout the Permian Basin, North Texas, and Southern Oklahoma (as well as third-party positions) to Targa’s fractionation and storage complex at Mont Belvieu. The acquisition price represents approximately 8.75...

AVEO Oncology Reminds Stockholders to Vote “FOR” All-Cash Transaction with LG Chem in advance of the Special Meeting of Stockholders

Written by Customer Service on January 3, 2023. Posted in Mergers And Acquisitions.

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend that AVEO Stockholders Vote “FOR” the Transaction BOSTON, Jan. 03, 2023 (GLOBE NEWSWIRE) — AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, reminds all AVEO stockholders to vote before AVEO’s Special Meeting of Stockholders (the “Special Meeting”) “FOR” the adoption of the Agreement and Plan of Merger among LG Chem, Ltd. (“LG Chem”), a subsidiary of LG Chem and AVEO (the “merger agreement”). Subject to the terms and conditions of the merger agreement, including obtaining requisite AVEO stockholder approval at the Special Meeting, LG Chem will acquire AVEO for merger consideration of $15.00 per share in cash. The Special...

Watsco Boosts Annual Dividend 11% to $9.80 Per Share

Written by Customer Service on January 3, 2023. Posted in Dividend Reports And Estimates.

49th Consecutive Year of Paying Dividends MIAMI, Jan. 03, 2023 (GLOBE NEWSWIRE) — Watsco, Inc.’s (NYSE: WSO) Board of Directors has declared a regular quarterly cash dividend of $2.45 on each outstanding share of its Common and Class B common stock payable on January 31, 2023 to shareholders of record at the close of business on January 17, 2023. Watsco has paid dividends to shareholders for 49 consecutive years. The Company’s philosophy is to share increasing amounts of cash flow through higher dividends while maintaining a conservative balance sheet with continued capacity to build its distribution network. Future changes in dividends are considered in light of investment opportunities, cash flow, general economic conditions and Watsco’s overall financial condition. About Watsco Watsco is the largest distribution network for...

Anfield to Acquire Marysvale and Calf Mesa Uranium Projects in Utah

Written by Customer Service on January 3, 2023. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, Jan. 03, 2023 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it has entered into a definitive agreement with Nedeel LLC & BBL-2 LLC (“the Sellers”) to acquire a 100% interest in 65 unpatented mining claims and historical data of the Marysvale uranium project, located in Beaver County, Utah, and 100% interest in 26 unpatented mining claims and historical data of the Calf Mesa uranium project, located in Emery County, Utah. Corey Dias, Anfield’s CEO commented: “We are pleased to secure additional claims near our Utah projects, including the Shootaring Canyon Mill, and will continue to seek out prospective assets which fit into our two-fold strategy of acquiring both near term and longer-term uranium and vanadium...

Great Elm Group Sells a Majority Interest in Forest Investments, Inc. to an Affiliate of JPMorgan Chase & Co.

Written by Customer Service on January 3, 2023. Posted in Mergers And Acquisitions.

The sale of a majority of its ownership interest in Forest Investments, Inc. is expected to ultimately raise approximately $45 million of cash on Great Elm Group’s Balance Sheet, enhancing its ability to focus exclusively on Investment Management. WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — Great Elm Group, Inc. (“we,” “us,” “our,” “GEG” or “Great Elm,”) (NASDAQ: GEG), an investment management company, today announced its sale of a majority of its ownership interest in Forest Investments, Inc. (“Forest”) to J.P. Morgan Broker-Dealer Holdings Inc. (“JPM”). Transaction HighlightsGEG has sold 61% of its direct and indirect common equity of Forest to JPM for approximately $18 million in cash. Together with its purchase of 20% of the common equity of Forest in December 2020, JPM owns 81% of Forest as of December 30, 2022. GEG...

Evaxion receives approval from FDA to proceed with the clinical Phase 2b study for EVX-01

Written by Customer Service on January 3, 2023. Posted in Public Companies.

COPENHAGEN, Denmark, Jan. 03, 2023 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, today announced that the U.S. Food and Drug Administration (“FDA”) determined that the Company may proceed with its Phase 2b clinical trial of EVX-01. In November 2022, the Company submitted an Investigational New Drug Application (“IND”) along with a Fast Track designation application to the FDA for a Phase 2b clinical trial of EVX-01 in combination with KEYTRUDA® for the treatment of patients with metastatic melanoma. On December 22, 2022, the FDA issued approval for the Company to proceed with its Phase 2b trial. The Company anticipates a response to the Fast Track designation submission in the first quarter...

First Tellurium Closes Third and Final Tranche of Private Placement, Engages IR Consultant and Grants Stock Options

Written by Customer Service on January 3, 2023. Posted in Public Companies.

THIS RELEASE IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, BC, Canada, Jan. 03, 2023 (GLOBE NEWSWIRE) — First Tellurium Corp. (CSE: FTEL, OTC FSTTF) (the “Company” or “First Tellurium”) announces it has closed the third and final tranche (the “Third Tranche“) of a non-brokered private placement (the “Offering”) previously announced on October 16, 2022. The Company has issued 1,250,000 units for gross proceeds of $125,000. Together with the first tranche closing announced November 17, 2022 for $404,000 (comprised of 2,600,000 flow-through shares at a price of $0.14 for proceeds of $364,000 and 400,000 units at $0.10 per unit for proceeds of $40,000), the second tranche closing of announced December 20, 2022 for $986,600 (comprised of 150,000 flow-through...

Nubeva Announces Projected Cash Flow Positive Operations in 2023

Written by Customer Service on January 3, 2023. Posted in Public Companies.

New Seven-Figure Contract Expected to Move Company Into The Black SAN JOSE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) — Nubeva Technologies (TSX-V: NBVA, OTCQB: NBVAF) today announced projected cash flow positive operations in the 2023 fiscal year following a new seven figure contract closed in December of 2022. “In less than one year, we have released our breakthrough ransomware reversal technology, built a robust pipeline, and are beginning to close significant deals, including a seven-figure contract at the end of the year. With that win, I expect we will be cashflow positive in our operations this year,” said Randy Chou, CEO and Founder of Nubeva. “At this point, I do not expect that Nubeva will need any further capital investments to maintain operations nor to fuel growth. I feel very good about where we are at this time.” Nubeva’s...

The Joint Corp. Increases Corporate Portfolio to 126 Clinics

Written by Customer Service on January 3, 2023. Posted in Mergers And Acquisitions.

— Opens Two Greenfield Clinics – – Purchased Six Previously Franchised Clinics – SCOTTSDALE, Ariz., Jan. 03, 2023 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, opened greenfield clinics and acquired six previously franchised clinics, increasing its corporate portfolio count to 126. “Executing our corporate portfolio growth plan, we continue to strategically open greenfields and opportunistically acquire franchises,” said President and CEO Peter D. Holt. “During 2022, we opened 16 greenfield clinics in locations complementary to existing sites in Arizona, California, Florida, New Mexico and Virginia, as well as in our new market – Kansas City. Throughout the year, we also purchased 16 previously franchised clinics. Net of selling...

Synlogic Announces Appointment of Dr. Dave Hava as Head of Research and Development

Written by Customer Service on January 3, 2023. Posted in Public Companies.

Dave Hava, Head of Research and Development, Synlogic Dave Hava, Head of Research and Development, SynlogicCAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, today announced the appointment of Dr. Dave Hava to Head of Research and Development effective January 1, 2023. “Developing a new therapeutic modality requires seamless integration of research and clinical development so that learnings from the clinic can be immediately applied to earlier programs,” said Aoife Brennan, M.B. Ch.B., Synlogic President and Chief Executive Officer. “Since joining the company, Dave has demonstrated the attributes required to take our programs and pipeline...

Month: January 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals